Significant Differences in Test Availability and Access to Novel Drugs for Multiple Myeloma between Public and Private Hospitals in Latin America. Grupo De Estudio Latinoamericano De Mieloma Multiple (GELAMM)

ConclusionLA is far from complying with international recommendations for MM approach. The most striking finding is the great difference between public and private centers in all variables. This gap is likely to translate into differences in survival, which is greatly concerning. Solving these inequities should be a priority.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Riva, E., Schutz, N. P., Pena, C., Villano, F., Ruiz-Arguelles, G. J., Navarro, J. R., Bujan, W., Andino Neves, L., Rojas, C., Lopez-Vidal, H., Rodriguez, A., Bove, V., Rodriguez, M., Fantl, D. B. Tags: 902. Health Services Research-Malignant Diseases: Poster I Source Type: research